This topic contains a solution. Click here to go to the answer

Author Question: One problem with NHST is that it can be misconstrued as an indicator of a. statistical ... (Read 7 times)

khang

  • Hero Member
  • *****
  • Posts: 569
One problem with NHST is that it can be misconstrued as an indicator of
 
  a. statistical significance.
  b. practical importance.
  c. theoretical significance.
  d. statistical differences.

Question 2

A 2  2 table of counts can be useful when computing which correlation coefficient?
 
  a. Spearman rho
  b. point-biserial
  c. phi coefficient
  d. Spearman-Brown coefficient



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

memslove

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

b

Answer to Question 2

c




khang

  • Member
  • Posts: 569
Reply 2 on: Jun 20, 2018
Wow, this really help


patma1981

  • Member
  • Posts: 292
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library